Liraglutide 3mg as a weight-loss strategy after failed bariatric surgery in a patient with hypothalamic obesity following craniopharyngioma.

Liraglutide 3mg as a weight-loss strategy after failed bariatric surgery in a patient with hypothalamic obesity following craniopharyngioma. Diabetes Metab. 2019 Jul 27;: Authors: Bretault M, Carette C, Zaharia R, Vychnevskaia K, Bouillot JL, Czernichow S, Raffin-Sanson ML PMID: 31362076 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31362076?dopt=Abstract

Source: Diabetes and Metabolism - July 26, 2019 Category: Endocrinology Authors: Bretault M, Carette C, Zaharia R, Vychnevskaia K, Bouillot JL, Czernichow S, Raffin-Sanson ML Tags: Diabetes Metab Source Type: research